Occupational bladder cancer: from cohort study to biologic molecular marker.

2005 ◽  
Vol 11 (10) ◽  
pp. RA311-RA315 ◽  
Author(s):  
Shiro Baba
Keyword(s):  
Bladder Cancer ◽  
Cohort Study ◽  
Molecular Marker

scholarly journals 92 Reshaping the Diagnostic Pathways for Investigation of Haematuria During and After The COVID-19 Pandemic: Diagnostic Accuracy of Strategies for Detection of Bladder Cancer from The IDENTIFY Cohort Study

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
S Khadhouri ◽  
K Gallagher ◽  
K MacKenzie ◽  
T Shah ◽  
C Gao ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cohort Study ◽  
Test Performance ◽  
Bladder Tumour ◽  
Healthcare Services ◽  
Diagnostic Strategies ◽  
Flexible Cystoscopy ◽  
Resource Limited ◽  
Diagnostic Test Performance ◽  
Diagnostic Pathways

Abstract Introduction Diagnostic haematuria services have been reduced due to the COVID-19 pandemic, compromising patient care, and necessitating a more pragmatic pathway. Method The IDENTIFY study was an international, prospective, multicentre cohort study of over 11,000 patients referred to secondary care for investigation of haematuria. Using this data, we developed strategies using combinations of imaging and cytology as triage tests to maximise cancer detection within a pragmatic pathway. Results 8112 patients (74·4%) received an ultrasound or a CT urogram, with or without cytology. 5737 (70·7%) patients had visible haematuria (VH) and 2375 (29·3%) had non-visible haematuria (NVH). Diagnostic test performance was used to determine optimal age cut-offs for four proposed strategies. We recommended proceeding directly to transurethral resection of bladder tumour for patients of any age with positive triage tests for cancer. Patients with negative triage tests under 35-years-old with VH, or under 50-years-old with NVH can safely be discharged without undergoing flexible cystoscopy. The remaining patients may undergo flexible cystoscopy, with a greater priority for older patients to capture high risk bladder cancer. Conclusions We suggest diagnostic strategies in patients with haematuria, which focus on detection of bladder cancer, whilst reducing the burden to healthcare services in a resource-limited setting.

scholarly journals Alcohol Consumption and Bladder Cancer Risk: Results from the Netherlands Cohort Study

2001 ◽  
Vol 153 (1) ◽  
pp. 38-41 ◽  
Author(s):  
Maurice P. A. Zeegers ◽  
Alex Volovics ◽  
Elisabeth Dorant ◽  
R. Alexandra Goldbohm ◽  
Piet A. van den Brandt
Keyword(s):  
Bladder Cancer ◽  
Cohort Study ◽  
Alcohol Consumption ◽  
Cancer Risk ◽  
The Netherlands ◽  
Bladder Cancer Risk

Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study

2020 ◽  
pp. 1-7
Author(s):  
Mohamed Kacem Ben Fradj ◽  
Mokhtar Bibi ◽  
Mohamed Bassem Hammami ◽  
Amani Kallel ◽  
Yassine Nouira ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Poor Outcomes

scholarly journals Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study

EBioMedicine ◽  
2020 ◽  
Vol 53 ◽  
pp. 102643 ◽  
Author(s):  
Md Ismail Hosen ◽  
Mahdi Sheikh ◽  
Maria Zvereva ◽  
Ghislaine Scelo ◽  
Nathalie Forey ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cohort Study ◽  
Clinical Diagnosis ◽  
Tert Promoter ◽  
Tert Promoter Mutations ◽  
Promoter Mutations
Sign in / Sign up

Export Citation Format

Share Document